<?xml version="1.0" encoding="UTF-8"?><marc:collection xmlns:marc="http://www.loc.gov/MARC21/slim">
  <marc:record>
    <marc:leader>00000nas  2200000za 4500</marc:leader>
    <marc:controlfield tag="001">9.504391</marc:controlfield>
    <marc:controlfield tag="003">CaOODSP</marc:controlfield>
    <marc:controlfield tag="005">20231114150211</marc:controlfield>
    <marc:controlfield tag="007">cr |||||||||||</marc:controlfield>
    <marc:controlfield tag="008">150406d20002001xxc|| p o||||f|   |0eng|d</marc:controlfield>
    <marc:datafield tag="040" ind1=" " ind2=" ">
      <marc:subfield code="a">CaOODSP</marc:subfield>
      <marc:subfield code="b">eng</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="043" ind1=" " ind2=" ">
      <marc:subfield code="a">n-cn---</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="086" ind1="1" ind2=" ">
      <marc:subfield code="a">H49-126E-PDF</marc:subfield>
      <marc:subfield code="z">H49-126E-IN</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="245" ind1="0" ind2="0">
      <marc:subfield code="a">Drugs of Current Interest (DOCI) list.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="264" ind1=" " ind2="1">
      <marc:subfield code="a">Ottawa, Ontario : </marc:subfield>
      <marc:subfield code="b">Health Canada</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="310" ind1=" " ind2=" ">
      <marc:subfield code="a">Quarterly</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="362" ind1="1" ind2=" ">
      <marc:subfield code="a">Began with October 2000; ceased with July 2001.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">"The purpose of the Drugs of current interest (DOCI) list is to stimulate reporting for a selected group of marketed drugs in order to identify drug safety signals. The maintenance of this list by the Canadian Adverse Drug Reaction Monitoring Program facilitates regular monitoring and constitutes one element of post-approval assessment activities."--Page 1.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="520" ind1="3" ind2=" ">
      <marc:subfield code="a">The purpose of the Drugs of current interest (DOCI) list is to stimulate reporting for a selected group of marketed drugs in order to identify drug safety signals. The maintenance of this list by the Canadian Adverse Drug Reaction Monitoring Program facilitates regular monitoring and constitutes one element of post-approval assessment activities.--Page 1</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="690" ind1="0" ind2="7">
      <marc:subfield code="a">Drugs</marc:subfield>
      <marc:subfield code="2">gcpds</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="710" ind1="1" ind2=" ">
      <marc:subfield code="a">Canada.</marc:subfield>
      <marc:subfield code="b">Health Canada. </marc:subfield>
      <marc:subfield code="b">Health Protection Branch, </marc:subfield>
      <marc:subfield code="e">issuing body.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="775" ind1="0" ind2="8">
      <marc:subfield code="t">Liste des Médicaments d'intérêt courant (MIC).</marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.500823</marc:subfield>
    </marc:datafield>
  </marc:record>
</marc:collection>
